We are live on ! Find out more
GTF

CYTOMEDIX INC COM NEW
GTF

Delisted

GTF was delisted on the 25th of January, 2011.

1 hedge funds and large institutions have $11K invested in CYTOMEDIX INC COM NEW in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less funds holding

Funds holding: 31 (-2)

73% less capital invested

Capital invested by funds: $40K → $11K (-$29K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1
Edge Wealth Management
New York
$11K
MGIA
2
Moneta Group Investment Advisors
Missouri
-$19K -43,101 Closed
PFM
3
Parsec Financial Management
North Carolina
-$9K -19,600 Closed

GTF Hedge Fund Activity: Q3 2013 in Review

1 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in CYTOMEDIX INC COM NEW (GTF) for Q3 2013, worth a combined $11K — down 73% from $40K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of GTF and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Moneta Group Investment Advisors, exiting entirely with an estimated $19K sold.

  • 1 institutional investor held CYTOMEDIX INC COM NEW (GTF) as of Q3 2013, down from 3 in Q2 2013.
  • Funds reported $11K of CYTOMEDIX INC COM NEW stock for Q3 2013, down 73% quarter-over-quarter.
  • 0 funds opened new CYTOMEDIX INC COM NEW positions in Q3 2013 and 2 closed out, a net change of -2 holders.
  • The largest CYTOMEDIX INC COM NEW seller in Q3 2013 was Moneta Group Investment Advisors, an estimated $19K sold.

Based on aggregated 13F filings for Q3 2013.